{
    "root": "aef69992-4a20-4d55-b85c-7c0799619ce6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "SEROQUEL",
    "value": "20250122",
    "ingredients": [
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8708"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "seroquel atypical antipsychotic indicated treatment : \u2022 schizophrenia ( 1.1 ) \u2022 bipolar disorder manic episodes ( 1.2 ) \u2022 bipolar disorder , depressive episodes ( 1.2 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 seroquel taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia - adults ( 2.2 ) 25 mg twice daily 150-750 mg/day 750 mg/day schizophrenia - adolescents ( 13-17 years ) ( 2.2 ) 25 mg twice daily 400-800 mg/day 800 mg/day bipolar mania - adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400-800 mg/day 800 mg/day bipolar mania - children adolescents ( 10-17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400-600 mg/day 600 mg/day bipolar depression - adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day \u2022 geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) \u2022 hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "bipolar depression (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            },
            {
                "text": "depression (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "25 mg tablets ( ndc 0310-0275-10 ) peach , round , biconvex , film coated tablets , identified \u2018 seroquel \u2019 \u2018 25 \u2019 one side plain side , supplied bottles 100 tablets . 50 mg tablets ( ndc 0310-0278-10 ) white , round , biconvex , film coated tablets , identified \u2018 seroquel \u2019 \u2018 50 \u2019 one side plain side , supplied bottles 100 tablets . 100 mg tablets ( ndc 0310-0271-10 ) yellow , round , biconvex film coated tablets , identified \u2018 seroquel \u2019 \u2018 100 \u2019 one side plain side , supplied bottles 100 tablets . 200 mg tablets ( ndc 0310-0272-10 ) white , round , biconvex , film coated tablets , identified \u2018 seroquel \u2019 \u2018 200 \u2019 one side plain side , supplied bottles 100 tablets . 300 mg tablets ( ndc 0310-0274-60 ) white , capsule-shaped , biconvex , film coated tablets , intagliated \u2018 seroquel \u2019 one side \u2018 300 \u2019 side , supplied bottles 60 tablets . 400 mg tablets ( ndc 0310-0279-10 ) yellow , capsule-shaped , biconvex , film coated tablets , intagliated \u2018 seroquel \u2019 one side \u2018 400 \u2019 side , supplied bottles 100 tablets . store 25\u00bac ( 77\u00baf ) ; excursions permitted 15-30\u00bac ( 59-86\u00baf ) [ usp ] .",
    "adverseReactions": "hypersensitivity quetiapine excipients seroquel formulation . anaphylactic reported patients treated seroquel .",
    "indications_original": "SEROQUEL is an atypical antipsychotic indicated for the treatment of: \u2022 Schizophrenia ( 1.1 ) \u2022 Bipolar I disorder manic episodes (1.2) \u2022 Bipolar disorder, depressive episodes (1.2)",
    "contraindications_original": "\u2022 SEROQUEL can be taken with or without food (2.1) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia - Adults (2.2) 25 mg twice daily 150-750 mg/day 750 mg/day Schizophrenia - Adolescents (13-17 years) (2.2) 25 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania - Adults Monotherapy or as an adjunct to lithium or divalproex (2.2) 50 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania - Children and Adolescents (10-17 years), Monotherapy (2.2) 25 mg twice daily 400-600 mg/day 600 mg/day Bipolar Depression - Adults (2.2) 50 mg once daily at bedtime 300 mg/day 300 mg/day \u2022 Geriatric Use : Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) \u2022 Hepatic Impairment : Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "25 mg Tablets (NDC 0310-0275-10) peach, round, biconvex, film coated tablets, identified with \u2018SEROQUEL\u2019 and \u201825\u2019 on one side and plain on the other side, are supplied in bottles of 100 tablets.\n                  50 mg Tablets (NDC 0310-0278-10) white, round, biconvex, film coated tablets, identified with \u2018SEROQUEL\u2019 and \u201850\u2019 on one side and plain on the other side, are supplied in bottles of 100 tablets.\n                  100 mg Tablets (NDC 0310-0271-10) yellow, round, biconvex film coated tablets, identified with \u2018SEROQUEL\u2019 and \u2018100\u2019 on one side and plain on the other side, are supplied in bottles of 100 tablets.\n                  200 mg Tablets (NDC 0310-0272-10) white, round, biconvex, film coated tablets, identified with \u2018SEROQUEL\u2019 and \u2018200\u2019 on one side and plain on the other side, are supplied in bottles of 100 tablets.\n                  300 mg Tablets (NDC 0310-0274-60) white, capsule-shaped, biconvex, film coated tablets, intagliated with \u2018SEROQUEL\u2019 on one side and \u2018300\u2019 on the other side, are supplied in bottles of 60 tablets.\n                  400 mg Tablets (NDC 0310-0279-10) yellow, capsule-shaped, biconvex, film coated tablets, intagliated with \u2018SEROQUEL\u2019 on one side and \u2018400\u2019 on the other side, are supplied in bottles of 100 tablets.\n                  Store at 25\u00baC (77\u00baF); excursions permitted to 15-30\u00baC (59-86\u00baF) [See USP].",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the SEROQUEL formulation. Anaphylactic reactions have been reported in patients treated with SEROQUEL.",
    "drug": [
        {
            "name": "SEROQUEL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8708"
        }
    ]
}